Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Central Pontine Myelinolysis : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Follow-up
Multimedia
References

Related Articles
Alcohol (Ethanol) Related Neuropathy

Brainstem Gliomas

Cerebellar Hemorrhage

Complex Partial Seizures

Diffuse Sclerosis

Intracranial Hemorrhage

Lacunar Syndromes

Leptomeningeal Carcinomatosis

Multiple Sclerosis

Subarachnoid Hemorrhage

Uremic Encephalopathy




Patient Education
Click here for patient education.



Author: Christopher Luzzio, MD, Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison

Christopher Luzzio is a member of the following medical societies: American Academy of Neurology

Editors: Howard A Crystal, MD, Professor, Departments of Neurology and Pathology, State University of New York Downstate; Consulting Staff, Department of Neurology, University Hospital and Kings County Hospital Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale; Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital; Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants

Author and Editor Disclosure

Synonyms and related keywords: osmotic myelinolysis, CPM, hyponatremia, noninflammatory demyelination, stripping of the myelin sheath, alcoholism, liver disease, malnutrition

Background

Adams et al described central pontine myelinolysis (CPM) as a unique clinical entity. They published their findings in 1958, observing that patients who suffered from alcoholism or malnutrition developed spastic quadriplegia, pseudobulbar palsy, and varying degrees of encephalopathy or coma from acute, noninflammatory demyelination that centered within the basis pontis.

Contemporary physicians recognize that CPM occurs inconsistently as a complication of severe and prolonged hyponatremia, particularly when corrected too rapidly. Standard of care requires judicious treatment of electrolyte disturbances to reduce the incidence of osmotic myelinolysis.

Pathophysiology

CPM is concentrated, frequently symmetric, noninflammatory demyelination within the central basis pontis. In at least 10% of patients with CPM, demyelination also occurs in extrapontine regions, including the mid brain, thalamus, basal nuclei, and cerebellum. The exact mechanism that strips the myelin sheath is unknown.

One theory proposes that in regions of compact interdigitation of white and gray matter, cellular edema, which is caused by fluctuating osmotic forces, results in compression of fiber tracts and induces demyelination. Prolonged hyponatremia followed by rapid sodium correction results in edema. During the period of hyponatremia, the concentration of intracellular charged protein moieties is altered; reversal cannot parallel a rapid correction of electrolyte status. The term "osmotic myelinolysis" is more appropriate than "central pontine myelinolysis" for demyelination occurring in extrapontine regions after the correction of hyponatremia.

Frequency

United States

The exact incidence of CPM is unknown. A study by Singh et al demonstrated that CPM was present in 29% of postmortem examinations of liver transplant patients. Two thirds of these patients had serum sodium fluctuations of only ± 15-20 mEq/L.

Mortality/Morbidity

See Follow-up.

Race

No reports exist of CPM in African Americans.

Sex

CPM occurs more frequently in females than in males.



History

A typical case of CPM can unfold as follows:

  • Severe hyponatremia is diagnosed in a person who presents to the emergency department with delirium. (Electrolyte disturbances frequently cause encephalopathy.)
  • IV fluid therapy is administered, and serum sodium is normal by the next day.
  • The patient's mental status improves, and he or she is more alert, but this is followed by neurologic deterioration 48-72 hours later.
  • Key features of the neurologic exam include confusion, horizontal gaze paralysis, and spastic quadriplegia.
  • Brain MRI reveals intense symmetric demyelination in the brain stem pons.

Physical

  • The most consistent examination findings are those of pseudobulbar palsy and spastic quadriplegia caused by demyelination of corticospinal and corticobulbar tracts within the pons.
  • Delirium is extremely common.
  • The volume of demyelination within the pons is variable. The loss of myelin can occur in adjacent brainstem areas and in more distal supratentorial locations. Thus, a diverse spectrum of examination findings and long-term disabilities are found.
    • Pseudobulbar palsy is characterized by head and neck weakness, dysphagia, and dysarthria.
    • Increased limb tone, limb weakness, hyperactive reflexes, and Babinski sign are typical features of spastic quadriplegia or lesions that involve upper motor neurons or the corticospinal tracts.
    • Lesions within the pons cause horizontal gaze paralysis.
    • Vertical ophthalmoparesis is caused by demyelination extending through the mid brain.
    • Coma or delirium results from lesions in the pontine tegmentum and/or thalamus.
    • Abnormalities in sensory modalities usually are not observed.
    • A large basis pontis lesion may cause a "locked-in syndrome," which includes paralysis of lower cranial nerves and limb musculature. Vertical eye movements, blinking, breathing, and alertness may remain intact in these patients.

Causes

Conditions predisposing patients to CPM include alcoholism, liver disease, malnutrition, and hyponatremia.

  • Risk factors for CPM in the hyponatremic patient include the following:
    • Serum sodium of less than 120 mEq/L for more than 48 hours
    • Aggressive IV fluid therapy with hypertonic saline solutions
    • Development of hypernatremia during treatment
  • Many patients who have hyponatremia that is corrected rapidly do not develop CPM. Thus, other less obvious risk factors probably exist.
  • Patients with an acute episode of hyponatremia that is treated promptly are unlikely to develop CPM.
  • CPM reportedly occurs occasionally in patients who are treated for hypernatremia.
  • CPM may complicate liver transplantation surgery.
    • Consider CPM when confusion and/or weakness complicate the liver transplant patient's postoperative recovery.
    • The author provided consultation for a liver transplant patient who developed CPM and critical illness neuromyopathy. The typical exam findings for CPM were masked by peripheral nerve and muscle disease. MRI studies provided conclusive evidence for brain stem demyelination.
  • Burn patients with a prolonged period of serum hyperosmolality are prone to developing CPM.
  • CPM also has occurred concurrently with Wilson disease and neoplasia.



Alcohol (Ethanol) Related Neuropathy
Brainstem Gliomas
Cerebellar Hemorrhage
Complex Partial Seizures
Diffuse Sclerosis
Intracranial Hemorrhage
Lacunar Syndromes
Leptomeningeal Carcinomatosis
Multiple Sclerosis
Subarachnoid Hemorrhage
Uremic Encephalopathy

Other Problems to be Considered

Brainstem hemorrhage
Cyclosporine neurotoxicity (liver transplant patients)
Brainstem syndromes



Lab Studies

  • Cerebral spinal fluid (CSF) probably is not necessary when the etiology and diagnosis are obvious.
  • CSF studies may demonstrate increased opening pressure, elevated protein, or mononuclear pleocytosis.

Imaging Studies

  • MRI or CT imaging of the brain stem may not reveal an obvious anatomic disturbance. A thorough neurologic exam therefore is indispensable.
  • MRI is the imaging modality of choice. Typically, T2-weighted MRI images demonstrate hyperintense or bright areas where demyelination has occurred caused by relatively increased water content in those regions.

Other Tests

  • Electroencephalography in CPM may demonstrate diffuse bihemispheric slowing.
  • Brainstem-evoked potentials may reveal abnormalities when neuroimaging is unrevealing.

Histologic Findings

Relative preservation of axons and surrounding neurons within areas of demyelination and an associated reduction in oligodendroglia is present.



Medical Care

Treatment is supportive only.

  • Correct hyponatremia at a rate of 10 µmol/L/24 h; diligently avoid hypernatremia. Details concerning the etiology and correction of electrolyte disorders are discussed extensively in general medicine texts.
  • Alcoholic patients should receive vitamin supplementation. Formally evaluate their nutritional status.

Consultations

  • Patients who survive CPM likely require extensive and prolonged neurorehabilitation.
  • Incorporate occupational, physical, speech, and language therapists early in the care of such patients.
  • Swallowing studies are necessary to evaluate for dysphagia and determine the risk for aspiration pneumonia.

Diet

See Consultations.

Activity

See Consultations.



Further Inpatient Care

Further Outpatient Care

  • The patient requires follow-up care with neurorehabilitation-associated services.

Transfer

  • Once medically stable, the patient should be evaluated by a neurorehabilitation specialist and, if appropriate, transferred for further inpatient recovery-oriented therapy.

Complications

  • Possible complications include those associated with severe central nervous system injury and reduced activity.
    • Ventilator dependency
    • Aspiration pneumonia
    • Venous thrombosis
    • Pulmonary embolism
    • Contractures
    • Muscle wasting
    • Decubitus ulcers
    • Urinary tract infections
    • Depression

Prognosis

  • Maximum recovery may require several months.
  • Chronic neurologic deficits range from "locked-in" syndrome to spastic quadriparesis.
  • Patients with extrapontine lesions may exhibit tremor and ataxia.
  • Death is common.



Media file 1:  T2-weighted MRI scan of the brain demonstrating patchy areas of signal change within the pons that are consistent with demyelination or central pontine myelinolysis. Courtesy of Dr Andrew Waclawik, Department of Neurology, University of Wisconsin, Madison.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  MRI



  • Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. Feb 1959;81(2):154-72. [Medline].
  • DeWitt LD, Buonanno FS, Kistler JP, et al. Central pontine myelinolysis: demonstration by nuclear magnetic resonance. Neurology. May 1984;34(5):570-6. [Medline].
  • Haspolat S, Duman O, Senol U, Yegin O. Extrapontine myelinolysis in infancy: report of a case. J Child Neurol. Nov 2004;19(11):913-5. [Medline].
  • Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore). Nov 1993;72(6):359-73. [Medline].
  • Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. Jan 1 1997;126(1):57-62. [Medline].
  • Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. Sep 2004;75 Suppl 3:iii22-8. [Medline].
  • Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore). Mar 1994;73(2):110-8. [Medline].

Central Pontine Myelinolysis excerpt

Article Last Updated: Jan 16, 2007